Company number 09389074
Status Active
Incorporation Date 14 January 2015
Company Type Private Limited Company
Address SANDRINGHAM HOUSE ACKHURST BUSINESS PARK, FOXHOLE ROAD, CHORLEY, LANCASHIRE, UNITED KINGDOM, PR7 1NY
Home Country United Kingdom
Nature of Business 74909 - Other professional, scientific and technical activities n.e.c.
Phone, email, etc
Since the company registration twenty-six events have happened. The last three records are Confirmation statement made on 14 January 2017 with updates; Statement of capital following an allotment of shares on 31 August 2016
GBP 3
; Statement by Directors. The most likely internet sites of SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED are www.synexusclinicalresearchmidcono1.co.uk, and www.synexus-clinical-research-midco-no-1.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and eleven months. Synexus Clinical Research Midco No 1 Limited is a Private Limited Company.
The company registration number is 09389074. Synexus Clinical Research Midco No 1 Limited has been working since 14 January 2015.
The present status of the company is Active. The registered address of Synexus Clinical Research Midco No 1 Limited is Sandringham House Ackhurst Business Park Foxhole Road Chorley Lancashire United Kingdom Pr7 1ny. . HARTMAN, Brainard Judd is a Director of the company. JAMES, Julia Mary is a Director of the company. NEILD, Christopher David is a Director of the company. Director BERTHOUX, Christophe has been resigned. Director CHAMBERS, Paul Michael has been resigned. Director EVANS, Hywel has been resigned. The company operates in "Other professional, scientific and technical activities n.e.c.".
Current Directors
Resigned Directors
Director
EVANS, Hywel
Resigned: 31 May 2016
Appointed Date: 18 February 2015
79 years old
Persons With Significant Control
Ppd International Investments Limited
Notified on: 17 November 2016
Nature of control: Ownership of shares – 75% or more
Synexus Clinical Research Topco Limited
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED Events
03 Feb 2017
Confirmation statement made on 14 January 2017 with updates
01 Feb 2017
Statement of capital following an allotment of shares on 31 August 2016
31 Aug 2016
Statement by Directors
31 Aug 2016
Statement of capital on 31 August 2016
31 Aug 2016
Solvency Statement dated 31/08/16
...
... and 16 more events
26 Mar 2015
Registration of charge 093890740002, created on 20 March 2015
13 Mar 2015
Appointment of Hywel Evans as a director on 18 February 2015
05 Mar 2015
Resolutions
-
RES13 ‐
(The "facilities agreement") (the "parent") ( the "agent") ((the "security agent") (the "intercreditor agreement") ("senior debenture") (the "documents"). The directors are authorised to take action regarding documents. 21/02/2015
-
RES01 ‐
Resolution of adoption of Articles of Association
-
RES01 ‐
Resolution of adoption of Articles of Association
24 Feb 2015
Registration of charge 093890740001, created on 22 February 2015
14 Jan 2015
Incorporation
Statement of capital on 2015-01-14